Portfolio manager with 50 years of experience shares 1970s bear-market lesson, and three stocks to buy now

A previous version of this column gave the incorrect date for the Fed policy decision. The story has been corrected. Investors looking at their screens this morning might feel a bit of relief, with oi...

Hang Seng slumps 3% over COVID lockdown worries, oil falls as Russian attacks in Ukraine intensify

BANGKOK (AP) — Stocks were mixed in Asia and oil prices fell Monday as uncertainty over the war in Ukraine and persistently high inflation kept investors guessing about what lies ahead. Tokyo and Sydn...

Whether or not a bottom is in, here’s what will ride to the stock market’s rescue over 12 months, one strategist forecasts

So, is this it? After the powerful 2.6% rebound for the S&P 500 SPX, -0.43% on Wednesday, is the bottom in? Arguing yes is Mark Newton, head of technical strategy at Fundstrat, who notes that whil...

DocuSign stock has lost its pandemic gains, and is plunging again after weak forecast

The pandemic gains for DocuSign Inc. shares have already disappeared, and the stock is still moving lower. DocuSign DOCU, -4.25% shares sank more than 15% in after-hours trading Thursday, following an...

Biogen Stock Has Fallen 50%. Why It’s Time to Buy.

Text size Biogen’s Alzheimer’s disease treatment was once expected to be a megablockbuster. Dominick Reuter/AFP via Getty Images Shares of the biotech firm Biogen are down 50% since June 1...

Novavax’s Revenue Falls Short. Management Expects a Surge.

Text size A doctor handles a vial holding a potential coronavirus vaccine at a Novavax lab in 2020. Andrew Caballero-Reynolds/AFP via Getty Images The Covid-19 vaccine maker Novavax expects sales of b...

3 simple rules for cushioning yourself against inflation

This article is reprinted by permission from NerdWallet.  Inflation — the rise in consumer prices — is a slow erosion of your money over time. Before 2021, the U.S. hadn’t seen annual core inflation m...

Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring

As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...

European stocks and U.S. equity futures wobble as Kremlin says U.S-Russia summit not a done deal

European stocks fell Monday, as investors clung to hopes that diplomacy will prevali over an increasingly tense Russia-Ukraine crisis. Technology stocks led the downside on the heels of sharp losses f...

What CEOs Are Saying: ‘We See Inflation Going Up Everywhere’

Here is what some of the world’s corporate leaders said in their quarterly earnings reports this week about inflation, pricing strategy and the pandemic. Coca-Cola Co. KO -1.78% Chief Executive James ...

Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance?

Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Text size Pfizer shares dropped sharply after the company’s 2022 sales guidance appeared to fall short of expectations. The guidance tha...

CVS Stock Is Tumbling. Lowered Range for Cash-Flow Guidance Unnerved Investors.

Text size CVS stock is falling after earnings. Bryan Bedder/Getty Images for CVS Pharmacy   CVS Health stock was falling after lowered cash-flow guidance overshadowed better-than-expected fourth-quart...

Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?

Text size Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Pfizer shares dropped sharply on Tuesday after the company’s 2022 sales guidance appeared to fall short of expectations. The g...

Novavax Stock Tumbles on Report That Vaccine Deliveries Are Lagging

Text size Novavax labs in Gaithersburg, Md. Andrew Caballero-Reynolds/AFP via Getty Images Novavax shares were plunging more than 15% Tuesday after the company acknowledged to Reuters that it has comp...

Pfizer Reports Earnings Tuesday. What to Expect.

Text size Pfizer is scheduled to report its earnings before the market opens on Tuesday. Jeenah Moon/Getty Images There’s no mystery about what 2022 will bring for Pfizer : Enormous, record-shattering...

The next ‘pain trade’ could be on the horizon as investors crowd into bets pegged to Fed monetary policy

Investors may be set up for the next so-called “pain” trade, with market participants increasingly coalescing around expectations that Federal Reserve needs to act aggressively to combat persistent U....

Nearly two years into the pandemic, Uber and Lyft still looking for a consistent lane

Nearly two years into the COVID-19 pandemic, the ride-hailing industry is still seeking stability. Uber Technologies Inc. UBER, +7.27% and Lyft Inc. LYFT, +3.63% are scheduled to release fourth-quarte...

The ‘best job in America’ pays $145,000, has 14,000 job openings — and offers a generous work-life balance

A six-figure salary and the option to work from home? It sounds too good to be true. Job openings are rising, while workers continue to quit. The number of vacant jobs hit 10.9 million in December, up...

Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.

In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...

Opinion: The party’s over: The Fed and Congress have pulled their support from workers and investors

Even as the government reports the fastest economic growth in nearly 40 years, the historic gains in income and wealth that inflated the economy in 2020 and 2021 are fading fast. The air is coming out...

Opinion: After a monster quarter, Apple’s non-forecast is good enough for Wall Street

Apple Inc.’s holiday sales and profit totals were staggering once again, and CEO Tim Cook gave just enough of a forecast to satisfy Wall Street on Thursday — but not enough to feel totally comfortable...

Opinion: Restaurant stocks are on the menu for investors as the pandemic’s end nears

Omicron is ripping through the population at a shocking rate, but there’s an upside. The coronavirus variant is milder and on track to leave the U.S. faster than delta. If so, this will favor “reopeni...

‘Good luck! We’ll all need it’: U.S. market approaches end of ‘superbubble,’ says Jeremy Grantham

The U.S. is approaching the end of a “superbubble” spanning across stocks, bonds, real estate and commodities following massive stimulus during the COVID pandemic, potentially leading to the largest m...

Johnson & Johnson’s got a new CEO and a plan to split the company in two. Here’s what else to expect out of J&J’s earnings

Johnson & Johnson JNJ, -0.31% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calendar and a business model that spans everything f...

China’s XI Doesn’t Want the Fed to Raise Rates Either

China’s President Xi Jinping urged the world’s major economies not to rapidly raise interest rates at the virtual Davos summit, warning such action could threaten the global recovery. The yield on the...

Credit Suisse Chairman Quits After Breaching Covid-19 Rules

Text size António Horta-Osório, former chairman of Credit Suisse AFP via Getty Images Credit Suisse Chairman António Horta-Osório has resigned only 8 monthsafter being appointed, following a board inv...

Is the stock market open today? Here are the trading hours on Martin Luther King Jr. Day

Stock and bond markets in the U.S. will be closed Monday, January 17 in observance of Martin Luther King, Jr. Day, offering traders a rest after a volatile start to the year. The Securities Industry a...

Is the Stock Market Open Today? These Are the Martin Luther King Jr. Day 2022 Hours.

Text size Traders work on the floor of the New York Stock Exchange. Spencer Platt/Getty Images Investors looking for a brief respite from two weeks of volatile trading on Wall Street may get one on Mo...

Value Gets Its Moment. Consider These Stocks and ETFs.

Buy the dip, wrote J.P. Morgan’s strategists early this past week. As calls to courage go, it wasn’t exactly Churchill during the Blitz. The dip in this case was a 2% decline, year to date, in the S&a...

The yield curve is no longer sending a don’t-worry-be-happy signal, warns bond king Jeffrey Gundlach

The S&P 500 SPX, +0.28% snapped a five-session losing streak on Tuesday, after Federal Reserve Chairman Jerome Powell vowed the central bank would use its “tools” to get inflation under control wi...

Biogen’s stock tumbles after the U.S. proposes restricting access to its Alzheimer’s disease drug

Biogen Inc.’s BIIB, -8.92% stock sank 9.3% in premarket trading on Wednesday, the day after regulators proposed limiting access to the class of Alzheimer’s disease drugs that includes the company’s th...

Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...